Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Peer Christiansen"'
Autor:
Hanne Marie Nellemann, Thomas Winther Buus, Anders Bonde Jensen, Finn Rasmussen, Peer Christiansen, Katrine Rye Hauerslev, Vibeke Løgager, Erik Morre Pedersen
Publikováno v:
Buus, T W, Rasmussen, F, Nellemann, H M, Løgager, V, Jensen, A B, Hauerslev, K R, Christiansen, P & Pedersen, E M 2021, ' Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy study ', European Radiology, vol. 31, no. 12, pp. 8838-8849 . https://doi.org/10.1007/s00330-021-08041-2
OBJECTIVES: To compare diagnostic accuracy of contrast-enhanced CT, dual-layer detector spectral CT (DL-CT), and whole-body MRI (WB-MRI) for diagnosing metastatic breast cancer.METHODS: One hundred eighty-two biopsy-verified breast cancer patients su
Autor:
Helle Mikel Hvid, Eva Balling, Peer Christiansen, Katrine Rye Hauerslev, Lone Fischer, Tine Engberg Damsgaard, Jens Overgaard
Publikováno v:
Hauerslev, K R, Overgaard, J, Damsgaard, T E, Hvid, H M, Balling, E, Fischer, L & Christiansen, P 2021, ' Oncoplastic breast surgery versus conventional breast conserving surgery-a prospective follow-up study of subjective loco-regional late morbidity ', Acta Oncologica, vol. 60, no. 6, pp. 750-759 . https://doi.org/10.1080/0284186X.2021.1900907
Hauerslev, K R, Overgaard, J, Damsgaard, T E, Hvid, H M, Balling, E, Fischer, L & Christiansen, P 2021, ' Oncoplastic breast surgery versus conventional breast conserving surgery–a prospective follow-up study of subjective loco-regional late morbidity ', Acta Oncologica, vol. 60, no. 6, pp. 750-759 . https://doi.org/10.1080/0284186X.2021.1900907
Hauerslev, K R, Overgaard, J, Damsgaard, T E, Hvid, H M, Balling, E, Fischer, L & Christiansen, P 2021, ' Oncoplastic breast surgery versus conventional breast conserving surgery–a prospective follow-up study of subjective loco-regional late morbidity ', Acta Oncologica, vol. 60, no. 6, pp. 750-759 . https://doi.org/10.1080/0284186X.2021.1900907
Background and aim: Few studies have focused on the symptoms of loco-regional morbidity in shoulders, arms, and breasts related to oncoplastic breast surgery (OPS). This study aimed to determine if a difference exists in the prevalence or variety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13bee5661c44b6984b9b29770567f62f
https://pure.au.dk/portal/da/publications/oncoplastic-breast-surgery-versus-conventional-breast-conserving-surgery--a-prospective-followup-study-of-subjective-locoregional-late-morbidity(0710f7f2-5139-443a-9c1d-79543958aebb).html
https://pure.au.dk/portal/da/publications/oncoplastic-breast-surgery-versus-conventional-breast-conserving-surgery--a-prospective-followup-study-of-subjective-locoregional-late-morbidity(0710f7f2-5139-443a-9c1d-79543958aebb).html
Autor:
Søren Feddersen, Cathrine Bredal Lythjohan, Thomas P. Ahern, Deirdre Cronin-Fenton, Anders Kjærsgaard, Peer Christiansen, Timothy L. Lash, Bent Ejlertsen, Per Damkier, Stephen Hamilton-Dutoit
Publikováno v:
Ahern, T P, Damkier, P, Feddersen, S, Kjærsgaard, A, Lash, T L, Hamilton-Dutoit, S, Lythjohan, C B, Ejlertsen, B, Christiansen, P M & Cronin-Fenton, D P 2020, ' Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin ', Acta Oncologica, vol. 59, no. 9, pp. 1009-1015 . https://doi.org/10.1080/0284186X.2020.1759820
Acta Oncol
Acta Oncol
Background: Statins treat hyperlipidemia and prevent cardiovascular morbidity and mortality. Evidence suggests that they also have anti-neoplastic activity. Several studies show a reduced rate of breast cancer recurrence among lipophilic statin users
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7599fe9f231f4b44d03ae47875a0159e
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
Autor:
Sinna Pilgaard Ulrichsen, Henrik Toft Sørensen, Lauren E. McCullough, Michael Goodman, Kristina B. Christensen, Kristina Lystlund Lauridsen, Per Damkier, Rami Yacoub, Lance A. Waller, Timothy L. Lash, Thomas P. Ahern, Bent Ejlertsen, Deirdre Cronin-Fenton, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit
Publikováno v:
Collin, L J, Ulrichsen, S P, Ahern, T P, Goodman, M, McCullough, L E, Waller, L A, Bang Christensen, K, Damkier, P, Hamilton-Dutoit, S, Lauridsen, K L, Yacoub, R, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Cronin-Fenton, D P & Lash, T L 2020, ' 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence : a Danish population-based study ', Acta Oncologica, vol. 59, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2019.1684560
Acta Oncol
Acta Oncol
BACKGROUND: Approximately 20–40% of patients diagnosed with breast cancer will experience a recurrence up to 20 years after their original diagnosis. 17?-hydroxysteroid dehydrogenase 1 and 2 (HSD17B1 and HSD17B2, respectively) regulate intratumoral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1221ea8ab1bf3d1024c9bb6d4f0751
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
Autor:
Tine Engberg Damsgaard, Peer Christiansen, Jens Overgaard, Anders Husted Madsen, Katrine Rye Hauerslev
Publikováno v:
Hauerslev, K R, Madsen, A H, Overgaard, J, Damsgaard, T E & Christiansen, P 2020, ' Long-term follow-up on shoulder and arm morbidity in patients treated for early breast cancer ', Acta Oncologica, vol. 59, no. 7, pp. 851-858 . https://doi.org/10.1080/0284186X.2020.1745269
Background: A prospective study on shoulder and arm morbidity was conducted in Denmark in 2003–2005. This study demonstrated that sentinel lymph node biopsy was associated with better outcomes than axillary lymph node dissection 18 months after sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed38346ace872835593ed259ddf0953e
https://pure.au.dk/portal/da/publications/longterm-followup-on-shoulder-and-arm-morbidity-in-patients-treated-for-early-breast-cancer(6322abf1-edcb-44ca-803c-9cf7a0fe5a51).html
https://pure.au.dk/portal/da/publications/longterm-followup-on-shoulder-and-arm-morbidity-in-patients-treated-for-early-breast-cancer(6322abf1-edcb-44ca-803c-9cf7a0fe5a51).html
Autor:
Per Damkier, Thomas P. Ahern, Stephen Hamilton-Dutoit, Anders Kjærsgaard, Lindsay J Collin, Peer Christiansen, Kristina B. Christensen, Deirdre Cronin-Fenton, Kristina Lystlund Lauridsen, Timothy L. Lash, Henrik Toft Sørensen, Rami Yacoub
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Damkier, P, Hamilton-Dutoit, S, Kjaersgaard, A, Lauridsen, K L, Yacoub, R, Christiansen, P, Sørensen, H T & Lash, T L 2019, ' Expression of survivin does not appear to influence breast cancer recurrence risk ', Acta Oncologica, vol. 58, no. 2, pp. 154-161 . https://doi.org/10.1080/0284186X.2018.1503419
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells.METHODS: We estimated the association between nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c5d4567c22bdcc224bb419fa7029e9
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
Autor:
Tinne Laurberg, Christina D Lyngholm, Peer Christiansen, Tine Engberg Damsgaard, Jan Alsner, Jens Overgaard
Publikováno v:
Lyngholm, C D, Laurberg, T, Alsner, J, Damsgaard, T E, Overgaard, J & Christiansen, P 2016, ' Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort ', Acta Oncologica, vol. 55, no. 8, pp. 983-992 . https://doi.org/10.3109/0284186X.2016.1156741
Based on the results from the DBCG 82 trial, breast conserving therapy (BCT) has been implemented as standard in Denmark since 1989, and today constitutes more than 70% of the primary treatment. Our aim was to evaluate the implementation of BCT as a
Autor:
Bent Ejlertsen, Birgitte Vrou Offersen, Peer Christiansen, Anne Vibeke Lænkholm, Ilse Vejborg, Henning T. Mouridsen, Maj-Britt Jensen, Henrik Flyger
Publikováno v:
Mouridsen, H, Christiansen, P, Jensen, M-B, Laenkholm, A-V, Flyger, H, Offersen, B, Vejborg, I & Ejlertsen, B 2018, ' Provision of data from the clinical database and of biological material from the tumor bank of the Danish Breast Cancer Cooperative Group 2008-2017 ', Acta Oncologica, vol. 57, pp. 1-3 . https://doi.org/10.1080/0284186X.2017.1403039
The capability to link health care information across various health care providers (institutions, clinics and professions) is increasingly recognized as an important source for clinical decision m...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621919661adc0e818fc9adfc930b5628
Autor:
Malgorzata K Tuxen, Mads K Hansen, M.H. Nielsen, Ilse Vejborg, Maj-Britt Jensen, Birgitte Vrou Offersen, Jens Overgaard, Bent Kristensen, Peer Christiansen, Henrik Flyger, Lisbet Rosenkrantz Hölmich, Anne-Marie Gerdes, Eva Balslev, Anne Vibeke Lænkholm, Henning T. Mouridsen, Bent Ejlertsen
Publikováno v:
Offersen, B V, Ejlertsen, B, Balslev, E, Flyger, H, Gerdes, A-M, Hansen, M K, Hølmich, L R, Jensen, M-B, Kristensen, B, Laenkholm, A-V, Mouridsen, H T, Nielsen, M H, Overgaard, J, Tuxen, M, Vejborg, I & Christiansen, P 2018, ' Is DBCG abreast of new developments? ', Acta Oncologica, vol. 57, no. 1, pp. 1-2 . https://doi.org/10.1080/0284186X.2017.1408960
The Danish Breast Cancer Group (DBCG) was established in 1977 by innovative and visionary clinicians and researchers diagnosing, treating and investigating breast cancer. The vision was to gather a...